Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $875.22 | 32 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $259.01 | 7 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $211.83 | 9 | $0 (2024) |
| Alkermes, Inc. | $167.61 | 4 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $83.15 | 3 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $67.12 | 4 | $0 (2023) |
| Indivior Inc. | $36.56 | 2 | $0 (2023) |
| ITI, Inc. | $19.02 | 1 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $15.49 | 1 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $15.43 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $90.10 | 4 | Neurocrine Biosciences, Inc. ($50.98) |
| 2023 | $346.34 | 12 | Alkermes, Inc. ($128.22) |
| 2022 | $363.59 | 13 | Janssen Pharmaceuticals, Inc ($147.01) |
| 2021 | $75.19 | 3 | Janssen Pharmaceuticals, Inc ($75.19) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/05/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $15.49 | General |
| 09/17/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: Neuroscience | ||||||
| 09/09/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $30.28 | General |
| Category: Neuropsychiatry | ||||||
| 02/28/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Neuropsychiatry | ||||||
| 12/06/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: Neuropsychiatry | ||||||
| 11/30/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: Neurology | ||||||
| 07/13/2023 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $103.43 | General |
| Category: CNS | ||||||
| 06/29/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $38.17 | General |
| Category: Neurology | ||||||
| 06/21/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: CNS | ||||||
| 06/14/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Neuroscience | ||||||
| 05/17/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: PSYCHIATRY | ||||||
| 04/26/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.22 | General |
| Category: Neuropsychiatry | ||||||
| 04/19/2023 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: BH | ||||||
| 04/13/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: Central Nervous System | ||||||
| 04/06/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: Neuropsychiatry | ||||||
| 02/01/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: PSYCHIATRY | ||||||
| 12/14/2022 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: INSOMNIA | ||||||
| 11/09/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: PSYCHIATRY | ||||||
| 10/26/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: Neuropsychiatry | ||||||
| 10/19/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neuroscience | ||||||
| 10/19/2022 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: CNS | ||||||
| 09/27/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: PSYCHIATRY | ||||||
| 09/21/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Neuropsychiatry | ||||||
| 09/14/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: CNS | ||||||
| 08/31/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 11 | 28 | $7,352 | $1,930 |
| 2021 | 2 | 25 | 33 | $5,657 | $1,885 |
| 2020 | 1 | 17 | 24 | $2,755 | $1,049 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 28 | $7,352 | $1,930 | 26.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 14 | 17 | $3,817 | $1,211 | 31.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 11 | 16 | $1,840 | $674.19 | 36.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 17 | 24 | $2,755 | $1,049 | 38.1% |
About Rachel Josefchuk, PMHNP
Rachel Josefchuk, PMHNP is a Psychiatric/Mental Health healthcare provider based in Flagstaff, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2019. The National Provider Identifier (NPI) number assigned to this provider is 1215580469.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Rachel Josefchuk, PMHNP has received a total of $875.22 in payments from pharmaceutical and medical device companies, with $90.10 received in 2024. These payments were reported across 32 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($875.22).
As a Medicare-enrolled provider, Josefchuk has provided services to 53 Medicare beneficiaries, totaling 85 services with total Medicare billing of $4,864. Data is available for 3 years (2020–2022), covering 4 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Location Flagstaff, AZ
- Active Since 07/17/2019
- Last Updated 09/22/2020
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1215580469
Products in Payments
- INVEGA SUSTENNA (Drug) $259.01
- INGREZZA (Drug) $211.83
- LYBALVI (Drug) $121.95
- UZEDY (Drug) $61.30
- ABILIFY MAINTENA (Drug) $52.96
- ARISTADA (Drug) $45.66
- PERSERIS (Drug) $36.56
- AUSTEDO (Drug) $21.85
- CAPLYTA (Drug) $19.02
- QUVIVIQ (Drug) $15.43
- REXULTI (Drug) $14.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Flagstaff
Mr. Phillip Dubravcic, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $1,904
Mr. Walt Hutton, Np, NP
Psychiatric/Mental Health — Payments: $876.78
Mrs. Amy Duschinski, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $368.76
Melanie Platt
Psychiatric/Mental Health — Payments: $257.05
Joan Moore, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $173.89
Jared Bennett, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $37.52